Michael Untch

73.9k citations
547 papers · 20.2k · 7 hit papers · h-index 66

Impact in

  • Cancer Research top 0.02%
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 0.05%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer Cells and Metastasis

Papers in

    • HER2/EGFR in Cancer Research 161
    • Cancer Treatment and Pharmacology 146
    • Cancer Cells and Metastasis 21
    • Breast Cancer Treatment Studies 262
    • Cancer Genomics and Diagnostics 37

Michael Untch

524 papers receiving 19.8k citations

Michael Untch's Hit Papers

Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 2024 · 68 citations
680+6+13Years since publication50010001.5k

Peers

Michael Untch
Comparison fields: 5 of 158
  • Cancer Research 8.4k
  • Oncology 9.4k
  • Radiology, Nuclear Medicine and Imaging 2.7k
  • Pathology and Forensic Medicine 1.7k
  • Pulmonary and Respiratory Medicine 2.8k
Replace Sandra M. Swain with:
Sandra M. Swain United States
Gϋnter von Minckwitz Germany
W. Eiermann Germany
Ana M. González-Angulo United States
Lyndsay N. Harris United States
Andreas Schneeweiß Germany
Steven Shak United States
Aňa Lluch Spain
Charles E. Geyer United States
Sibylle Loibl Germany
Michael Untch relative to Sandra M. Swain United States Sandra M. Swain's profile →
Citations per field
00.5×1.5×
Sandra M. Swain · 1×
Citations per year

Countries citing papers authored by Michael Untch

Since Specialization
Citations

This map shows the geographic impact of Michael Untch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Untch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Untch more than expected).

Fields of papers citing papers by Michael Untch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Untch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Untch. The network helps show where Michael Untch may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Untch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Untch Line = papers co-authored together Michael Untch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 547 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Hit paper breakdown →
20121873
2
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
Hit paper breakdown →
2013951
3
Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells
Hit paper breakdown →
2006714
4
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
Hit paper breakdown →
2017704
5
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
Hit paper breakdown →
2006548
6
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
Hit paper breakdown →
2018537
7 2003454
8 2010410
9 2010402
10 2011373
11 2001325
12 2007299
13 2012299
14 2007278
15 2013269
16 2003265
17 2012264
18 2001262
19
Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
1995245
20 2004231

About Michael Untch

Michael Untch is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 547 papers that have together received 20.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (262 papers), HER2/EGFR in Cancer Research (161 papers), Cancer Treatment and Pharmacology (146 papers), Advanced Breast Cancer Therapies (119 papers), Breast Lesions and Carcinomas (47 papers), Cancer Genomics and Diagnostics (37 papers), Monoclonal and Polyclonal Antibodies Research (34 papers) and Cancer Cells and Metastasis (21 papers). The work is most often cited by research in Cancer Research (8.4k citations), Oncology (9.4k citations), Radiology, Nuclear Medicine and Imaging (2.7k citations), Pathology and Forensic Medicine (1.7k citations) and Pulmonary and Respiratory Medicine (2.8k citations). Michael Untch has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Gϋnter von Minckwitz, Sibylle Loibl, Christian Jackisch, Jens Huober, Gottfried E. Konecny, Peter A. Fasching, Jens‐Uwe Blohmer, Valentina Nekljudova, Ingo Bauerfeind and Carsten Denkert. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Care and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact